Clinical results and risk factors of proton and carbon ion therapy for hepatocellular carcinoma

Abstract

Proton and carbon ion therapies for HCC were comparable in terms of local control and overall survival rates. These therapies may represent innovative alternatives to conventional local therapies for HCC.